Want to join the conversation?
Pharmacy benefit manager $ESRX reported a jump in 2Q16 earnings driven by lower costs and expenses despite a slight decline in revenues. Net income rose to $720.7MM or $1.13 per share from $600.1MM or $0.88 per share last year. Revenues slid to $25.22Bil from $25.45Bil. Adjusted EPS grew to $1.57 from $1.44.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.